SCHEMBL496204

SCHEMBL496204

CCCCN1CCC(Nc2cc(C(F)(F)F)ccc2C(=O)Nc2ccc3c(c2)NC(=O)C3(C)C)CC1

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
UBE2M P61081 10/20 0.43
DCUN1D1 Q96GG9 10/20 0.43
SLC6A5 Q9Y345 1/20 0.41
LCK P06239 1/20 0.39
MAPK14 Q16539 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TRPV4 Q9HBA0 3/20 0.38
CCR2 P41597 1/20 0.38
TRPV1 Q8NER1 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
SCN10A Q9Y5Y9 2/20 0.37
SCN8A Q9UQD0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL496366 0.93 UBE2M (0.39) UBE2MDCUN1D1SLC6A5LCKMAPK14
SCHEMBL496258 0.88 SCN10A (0.38) UBE2MDCUN1D1LCKMAPK14MEN1
SCHEMBL10129624 0.84 TRPV4 (0.40) TRPV4TRPV1RXFP1SCN10ASCN8A
SCHEMBL10129642 0.81 FLT3 (0.47) TRPV4TRPV1RXFP1SCN10ASCN8A
SCHEMBL10129645 0.81 FLT3 (0.47) TRPV4TRPV1RXFP1SCN10ASCN8A
SCHEMBL496209 0.79 TRPV1 (0.39) TRPV1RXFP1SCN10ASCN8A
SCHEMBL496026 0.79 TRPV1 (0.39) TRPV1RXFP1SCN10ASCN8A
SCHEMBL496111 0.79 TRPV1 (0.39) TRPV1RXFP1SCN10ASCN8A
Hydrochloric Acid SCHEMBL496005 0.78 SCN8A (0.39) TRPV1RXFP1SCN10ASCN8A
SCHEMBL495747 0.78 SCN10A (0.40) TRPV1RXFP1SCN10ASCN8A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1955697-B1 2-AMINOBENZAMIDE DERIVATIVES AS VANILLOID RECEPTOR 1 (VR1) INHIBITORS USEFUL FOR THE TREATMENT OF PAIN OR BLADDER FUNCTION DISORDER ASTELLAS PHARMA INC (JP) 2012-05-02 EP claimed
US-8106190-B2 2-aminobenzamide derivatives ASTELLAS PHARMA INC. (JP) 2012-01-31 US claimed